The medical community pointing out the issues with low insurance fee of the essential and critical medical care

Gettyimagebank A nurse Died of a brain hemorrhage while on duty at AsanMedical Center Died after transferto SNU Hospital in the absence of a doctor clipping capability… The medical community pointing out the issues with low insurance fee of the essential and critical medical care [Medigatenews] A nurse collapsed from a cerebral hemorrhage while working at Seoul Asan Medical Center on the 24th of last month shockingly died after being transferred to Seoul National University Hospital. According t

​Korea ‘Sweet dream’ project, Sleep Tech 2022 successfully held

Korea ‘Sweet dream’ project, Sleep Tech 2022 successfully held 3 days from July 15th to 17th at COEX Hall D... Sleep related products exhibition and consultation/seminar [MedigateNews] SleepTech 2022, which celebrated its 3rd anniversary this year, was successfully held at COEX Hall D (3rd floor) in Samseong-dong, Seoul for three days from the 15th to the 17th. Under the slogan of ‘Everyday Good Morning’, this exhibition presents new sleep health trends and directions, and provides consumers wit

How to distinguish intestinal pseudo-obstruction from mechanical obstruction

Professor Myung-gyu Choi of Gastroenterology Department at Seoul St. Mary's Hospital. [관련기사=수술로 장 마비 해결 안되는 가성 장폐색, 기계적 장폐색과 어떻게 구분할까] How to distinguish intestinal pseudo-obstruction from mechanical obstruction Chronic Intestinal Pseudo-obstruction is a disease in which the nerves and muscles of the small intestine are slowly damaged over a long period due to systemic diseases such as diabetes, amyloidosis, and Parkinson's disease. Patients usually do not seem to have any problems in a stable s

The market cap of the listed Korean biopharmaceutical companies plummeting amid COVID-19 endemic

Gettyimages Bank. [관련기사=코로나 팬데믹으로 훈풍 불었던 제약바이오 주가…엔데믹 초읽기에 시총 급락세] Until last year, as the COVID-19 pandemic became severe, the stock price of biopharmaceutical rose sharply due to the expectations for the development of vaccines, treatments, and the strengthened government supports. As the number of confirmed cases has recently dropped significantly and the fatality rate has fallen sharply, the stock price of biopharmaceutical is also fluctuating. MedigateNews compared biopharmaceutical compani

'snatching of the Nursing Act'... The representatives of Doctors to hold a rally on the 15th

The medical community outraged at the Democratic Party's 'snatching of the Nursing Act'... the representatives of Korean Doctors to hold a rally on the 15th Welfare committee plenary meeting and judiciary committee pledged to fight vigorously due to snatching of the bill [관련기사=전국 의사 대표자들 200여명 궐기대회 "간호법 철회될 때까지 강력 투쟁"(종합)] [MedigateNews] The Nursing Act, which had been with held at the 1st Bill Subcommittee of the Health and Welfare Committee of the National Assembly on April 27, was passed urge

Korean microbiome companies giving efforts to challenge CDMO business beyond new drug development

Gettyimages Bank. [관련기사=마이크로바이옴 신약개발 가장 큰 허들 'CDMO(위탁개발생산)' 국내 부재 현실 속 도전기관은?] At Bio Korea 2022 held on the 11th, Korean microbiome companies such as Genome & Company, GoBio Lab, and CJ expressed their aspirations to not only develop new drugs but also directly engage in CDMO development in the future. Park Cheol-won, CEO of GoBioLab, said, "After setting up a development organization in 2018, we received approval for phase 1 clinical IND in 2019 and phase 2 IND by the FDA in 2020, and we are c

Following Daewoong and Chong Kun Dang, the medium-sized companies also secured pipelines for Exosome

Gettyimages Bank. [관련기사=38조원 시장 성장 예측 엑소좀, 대웅·종근당 이어 중견기업들도 파이프라인 확보 나서] Large Korean pharmaceutical companies are expanding their research and investment bases for exosomes, and biotech companies are also paying attention to this and are strengthening their pipelines. Earlier this year, Daewoong Pharmaceutical and Exostemtech decided to establish a technology for extracting and purifying exosomes from the stem cells of Daewoong Pharmaceutical's DW-MSC, and to conduct joint development of exosom

K-bio companies invested by pharma companies and VCs in the first quarter

Gettyimages Bank. [관련기사=1분기 국내 제약사와 VC들이 투자한 바이오사는…대기업도 전략적투자자로 적극 참여] In the first quarter of the Korean bio market, it was found that BotaMedi succeeded in attracting the largest investment by receiving about 800 billion won from venture capitals(VCs). Based on the published data, MedigateNews analyzed the investment status of biohealth ventures in Korea in the first quarter of 2022, and it was found that about 50 companies received about 1.5 trillion won in investment. Ventures showed great i

"Moderna will try to execute our strategy to address Omicron variantas fast as possible"

Dr. Randall N. Hyer, Global Vice President, Medical Affairs, Moderna Global Medicine [관련기사=하이엘 모더나 글로벌 부사장 "바이러스 진화하고 질병패턴 변하기 때문에 코로나19 백신 접종 중요"] [MedigateNews] Moderna, one of COVID-19 mRNA vaccine development leaders, recently established a branch office in Korea and appointed a Representative Director to announce the start of their business officially. Dr. Randall N. Hyer, Vice President, Global Medical Affairs, Moderna ane and Hee-soo Kim, Medical Director, Moderna Korea presented their ef

How would you describe Lee Pil-Soo who is the 41st chairman-elect of Korean Medical Association

[관련기사=제41대 의협회장 이필수 당선인은 누구..."투쟁보단 최선의 협상, 화합하는 리더"] How would you describe Lee Pil-Soo who is the 41st chairman-elect of Korean Medical Association…“A leader who negotiates and unites in the best way rather than struggles” Lee Pil-Soo who is the Chairman of Jeonlanam-do Medical Association and the Vice Chairman of the Korean Medical Association, was elected as the 41st chairman of Korean Medical Association. The members selected a leader who is able to negotiate with the Government and Nationa